BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31229654)

  • 1. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
    Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
    J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data.
    Schnidrig D; Garofoli A; Benjak A; Rätsch G; Rubin MA; ; Piscuoglio S; Ng CKY
    Genomics; 2023 Mar; 115(2):110587. PubMed ID: 36796655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PipeIT2: Somatic Variant Calling Workflow for Ion Torrent Sequencing Data.
    Garofoli A; Schnidrig D; Ng CKY
    Methods Mol Biol; 2022; 2493():195-204. PubMed ID: 35751816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.
    Deshpande A; Lang W; McDowell T; Sivakumar S; Zhang J; Wang J; San Lucas FA; Fowler J; Kadara H; Scheet P
    BMC Bioinformatics; 2018 Jan; 19(1):5. PubMed ID: 29301485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
    Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
    Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
    Werner R; Connolly A; Bennett M; Hand CK; Burke L
    J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples.
    Nagashima T; Shimoda Y; Tanabe T; Naruoka A; Saito J; Serizawa M; Ohshima K; Urakami K; Ohnami S; Ohnami S; Mochizuki T; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(6):359-366. PubMed ID: 28003583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
    Sun S; Thorson JA; Murray SS
    Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.
    Wünsch C; Banck H; Müller-Tidow C; Dugas M
    BMC Med Genomics; 2020 Feb; 13(1):17. PubMed ID: 32019565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VarBen: Generating in Silico Reference Data Sets for Clinical Next-Generation Sequencing Bioinformatics Pipeline Evaluation.
    Li Z; Fang S; Zhang R; Yu L; Zhang J; Bu D; Sun L; Zhao Y; Li J
    J Mol Diagn; 2021 Mar; 23(3):285-299. PubMed ID: 33346148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
    Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
    BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.
    Dacheva D; Dodova R; Popov I; Goranova T; Mitkova A; Mitev V; Kaneva R
    Mol Diagn Ther; 2015 Apr; 19(2):119-30. PubMed ID: 25893891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
    Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
    J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.